Joel Charrow
Clinical Genetics (M.D.) · Chicago, ILNPI 1962466375
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $131,526 of the $189,327 with a category attached, or 69.5%. Sanofi accounts for 78.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $51,197 and has fallen 78.1% since, to $11,202 in 2025.
Across 147 payments — averaging $1287.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$149K
- Biomarin Pharmaceutical Inc.$23K
- Shire North American Group Inc$11K
- Bioverativ Therapeutics Inc.$3K
- Sanofi US Services Inc.$2K
- Applied Therapeutics, Inc.$600
- plus $97 from 2 others
Across 230 payments — averaging $9180.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$1.4M
- Sanofi$608K
- Amicus Therapeutics, Inc.$40K
- Merck$19K
- Sanofi US Services Inc.$12K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
What the payments were for
- Consulting fees$131,52669%
- Speaking & faculty fees$29,52916%
- Travel & lodging$23,27512%
- Food & beverage$4,2712%
- Education$7260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 115 | $148,883 |
| Biomarin Pharmaceutical Inc. | 14 | $23,177 |
| Shire North American Group Inc | 9 | $11,411 |
| Bioverativ Therapeutics Inc. | 3 | $2,834 |
| Sanofi US Services Inc. | 1 | $2,325 |
| Applied Therapeutics, Inc. | 1 | $600 |
| Sanofi-aventis U.S. LLC | 2 | $52 |
| Nobelpharma America, LLC | 2 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERDELGA$35,650
- FABRAZYME$21,936
- CEREZYME$15,974
- VPRIV$7,078
- LUMIZYME$3,864
- NO PRODUCT DISCUSSED$2,825
- VOXZOGO 1.2mg$138
How this compares
Too few clinical genetics (m.d.) providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Chicago
- Barbara BurtonChicago$762K
- Carlos PradaChicago$303K
- Joshua BakerChicago$221K
- William DobynsChicago$2K
- Susan EchiverriChicago$2K
- Miguel BarajasChicago$1K
- Brandon ChalazanChicago$603
- Gifty BhatChicago$149
- Mindy LiChicago$49
- George HogansonChicago$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.